Literature DB >> 9712406

Aromatase inhibitors in advanced breast cancer: mechanism of action and clinical implications.

A M Brodie1, V C Njar.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1998        PMID： 9712406     DOI： 10.1016/s0960-0760(98)00022-3

Source DB:  PubMed          Journal:  J Steroid Biochem Mol Biol        ISSN： 0960-0760            Impact factor:   4.292


× No keyword cloud information.
  8 in total

Review 1.  Breast cancer.

Authors:  Monica Morrow; William Gradishar
Journal:  BMJ       Date:  2002-02-16

Review 2.  Recent Progress in the Discovery of Next Generation Inhibitors of Aromatase from the Structure-Function Perspective.

Authors:  Debashis Ghosh; Jessica Lo; Chinaza Egbuta
Journal:  J Med Chem       Date:  2016-01-19       Impact factor: 7.446

Review 3.  Epigenetics in breast and prostate cancer.

Authors:  Yanyuan Wu; Marianna Sarkissyan; Jaydutt V Vadgama
Journal:  Methods Mol Biol       Date:  2015

4.  Docking and 3D-QSAR studies of diverse classes of human aromatase (CYP19) inhibitors.

Authors:  Partha Pratim Roy; Kunal Roy
Journal:  J Mol Model       Date:  2010-03-01       Impact factor: 1.810

5.  Effects of cyclin D1 gene amplification and protein expression on time to recurrence in postmenopausal breast cancer patients treated with anastrozole or tamoxifen: a TransATAC study.

Authors:  Katja Lundgren; Matthew Brown; Silvia Pineda; Jack Cuzick; Janine Salter; Lila Zabaglo; Anthony Howell; Mitch Dowsett; Göran Landberg
Journal:  Breast Cancer Res       Date:  2012-04-04       Impact factor: 6.466

6.  3β,11α-Dihy-droxy-17a-oxa-d-homoandrost-5-en-17-one.

Authors:  Alina Swizdor; Agata Białońska; Teresa Kołek; Anna Panek
Journal:  Acta Crystallogr Sect E Struct Rep Online       Date:  2010-07-14

7.  Pharmacokinetics of anastrozole and tamoxifen alone, and in combination, during adjuvant endocrine therapy for early breast cancer in postmenopausal women: a sub-protocol of the 'Arimidex and tamoxifen alone or in combination' (ATAC) trial.

Authors:  M Dowsett; J Cuzick; A Howell; I Jackson
Journal:  Br J Cancer       Date:  2001-08-03       Impact factor: 7.640

8.  Predicting the Benefit of Adjuvant Aromatase Inhibitor Therapy in Postmenopausal Breast Cancer Patients with Phosphorylated S6K1 Expression Status.

Authors:  Jihye Choi; Chan Sub Park; Min-Ki Seong; Hyesil Seol; Jae-Sung Kim; In-Chul Park; Woo Chul Noh; Hyun-Ah Kim
Journal:  J Breast Cancer       Date:  2019-12-31       Impact factor: 3.588
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.